Partnership will pursue cellular therapies for hard-to-treat wounds

04/9/2012 | Pharmaceutical Business Review Online

The human-based protein Elastatropin and technology involving adipose-derived stem cells and stromal cell culture media will be used to develop cellular treatments for wound healing and regenerative therapies. American CryoStem and Protein Genomics have formed a partnership that will focus on therapies for difficult-to-treat conditions.

View Full Article in:

Pharmaceutical Business Review Online

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ